 | Up a level |
2022
Nelke, Christopher, Schroeter, Christina B., Stascheit, Frauke 
ORCID: 0000-0001-5306-7880, Pawlitzki, Marc, Regner-Nelke, Liesa, Huntemann, Niklas, Arat, Ercan, Oeztuerk, Menekse, Melzer, Nico ORCID: 0000-0002-2420-701X, Mergenthaler, Philipp, Gassa, Asmae, Stetefeld, Henning, Schroeter, Michael, Berger, Benjamin ORCID: 0000-0003-2654-2898, Totzeck, Andreas, Hagenacker, Tim, Schreiber, Stefanie ORCID: 0000-0003-4439-4374, Vielhaber, Stefan, Hartung, Hans-Peter, Meisel, Andreas ORCID: 0000-0001-7233-5342, Wiendl, Heinz, Meuth, Sven G. and Ruck, Tobias
(2022).
Eculizumab versus rituximab in generalised myasthenia gravis.
J. Neurol. Neurosurg. Psychiatry, 93 (5).
S. 548 - 555.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-330X
Nelke, Christopher, Stascheit, Frauke ORCID: 0000-0001-5306-7880, Eckert, Carmen, Pawlitzki, Marc, Schroeter, Christina B., Huntemann, Niklas, Mergenthaler, Philipp, Arat, Ercan, ozturk, Menekse, Foell, Dirk, Schreiber, Stefanie, Vielhaber, Stefan, Gassa, Asmae, Stetefeld, Henning, Schroeter, Michael, Berger, Benjamin ORCID: 0000-0003-2654-2898, Totzeck, Andreas, Hagenacker, Tim, Meuth, Sven G., Meisel, Andreas ORCID: 0000-0001-7233-5342, Wiendl, Heinz and Ruck, Tobias
(2022).
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients.
J. Neuroinflamm., 19 (1).
LONDON:
BMC.
ISSN 1742-2094
2021
Rolfes, Leoni, Pawlitzki, Marc, Pfeuffer, Steffen, Nelke, Christopher, Lux, Anke, Pul, Refik, Kleinschnitz, Christoph ORCID: 0000-0002-1650-8875, Kleinschnitz, Konstanze, Rogall, Rebeca, Pape, Katrin, Bittner, Stefan, Zipp, Frauke ORCID: 0000-0002-1231-1928, Warnke, Clemens, Goereci, Yasemin, Schroeter, Michael, Ingwersen, Jens, Aktas, Orhan, Klotz, Luisa, Ruck, Tobias ORCID: 0000-0001-6332-8650, Wiendl, Heinz and Meuth, Sven G.
(2021).
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Neurol.-Neuroimmunol. Neuroinflammation, 8 (5).
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 2332-7812